Argolyn Bioscience
Latest round
- Series A
Last raised
- Jun 2007
Total raised
- $4.8M
Investors
- 3
About Argolyn Bioscience
Argolyn Bioscience Inc. is a privately held biopharmaceutical company dedicated to discovering and developing novel peptide drug candidates to treat psychosis, pain, and other serious diseases and disorders.
Who invested in Argolyn Bioscience
3 investors across 1 round
See all investors in Argolyn Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 5, 2007
Amount
$4.8M
Investors
Questions about Argolyn Bioscience
Who invested in Argolyn Bioscience?
Argolyn Bioscience has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Argolyn Bioscience raised?
Argolyn Bioscience has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Argolyn Bioscience last raise money?
Argolyn Bioscience's most recent round on record is a Series A, in Jun 2007.
What does Argolyn Bioscience do?
Argolyn Bioscience is a biotechnology company.
Where is Argolyn Bioscience headquartered?
Argolyn Bioscience is headquartered in Durham, US.
Which VCs invest in companies like Argolyn Bioscience?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Argolyn Bioscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Argolyn Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.